Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation.

Vitale, Mario

Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. [electronic resource] - Thyroid : official journal of the American Thyroid Association Apr 2013 - 517-9 p. digital

Publication Type: Letter

1557-9077

10.1089/thy.2012.0614 doi


Humans
Protein Kinase Inhibitors--therapeutic use
Thyroid Neoplasms--drug therapy